Bioventus Inc. (BVS) vs Tandem Diabetes Care, Inc. (TNDM)
- Bioventus Inc. BVS 13.30 −3.69%
- Tandem Diabetes Care, Inc. TNDM 16.17 −2.12%
Bioventus Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Bioventus Inc. and Tandem Diabetes Care, Inc. are of similar size ($1.2B and $1.2B). Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 16.4×. Tandem Diabetes Care, Inc. grew revenue faster over the last twelve months: 3.96% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −6.08%) and the higher return on invested capital (7.34% vs −10.3%). Across the 19 metrics below, Bioventus Inc. leads on 13 and Tandem Diabetes Care, Inc. on 6.
Valuation
Profitability
| Metric | BVS | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.65% | 56.01% | 56.01% |
| Operating margin | 10.02% | (4.40%) | (15.03%) |
| Net margin | 9.36% | (6.08%) | (20.40%) |
| Free cash flow margin | 16.20% | (2.56%) | (7.24%) |
| Return on equity | 22.75% | (48.03%) | (15.32%) |
| Return on assets | 7.89% | (6.24%) | (19.72%) |
| Return on invested capital | 7.34% | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack